Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/1/2018
SIETES contiene 92183 citas

<< anterior 21 a 40 de 175 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Kovatchev B. Closed loop control for type 1 diabetes. BMJ 2011;342:883-4. [Ref.ID 90474]
24.Tiene citas relacionadas
Scott I. Improving the accuracy of predicting cardiovascular risk. BMJ 2010;340:1206-7. [Ref.ID 88633]
25.Enlace a cita original Cita con resumen
Garcia F, Montero Alonso MJ, Merino Senovilla A, Sanz Cantalapiedra R, Maderuelo JA. Las cifras mágicas en la prevención farmacológica de la enfermedad cardiovascular y de fracturas. Boletín de Información Farmacoterapéutica de Navarra 2009;17:49-63. [Ref.ID 87090]
28.Tiene citas relacionadas Cita con resumen
Jackson R, Marshall R, Kerr A, Riddell T, Wells S. QRISK or Framingham for predicting cardiovascular risk?. BMJ 2009;339:115-6. [Ref.ID 86339]
30. Cita con resumen
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro III AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, +, Greene T, Coresh J, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12. [Ref.ID 85873]
31. Cita con resumen
Pickering JW, Endre ZH. GFR shot by RIFLE: errors in staging acute kidney injury. Lancet 2009;373:1318-9. [Ref.ID 85656]
32. Cita con resumen
Aronson JK, Price D, Ferner RE. A strategy for regulatory action when new adverse effects of a licensed product emerge. Drug Saf 2009;32:91-8. [Ref.ID 85478]
33.Tiene citas relacionadas Cita con resumen
The International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 2009;360:753-64. [Ref.ID 85287]
34.Tiene citas relacionadas Cita con resumen
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials. Diabetes Care 2009;32:187-92. [Ref.ID 85102]
35.Tiene citas relacionadas Cita con resumen
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009;32:193-203. [Ref.ID 85101]
Scott IA. Evaluating cardiovascular risk assessment for asymptomatic people. BMJ 2009;338:164-8. [Ref.ID 85033]
37.Tiene citas relacionadas Cita con resumen
Schneeweiss S, Avorn J. Antipsychotic agents and sudden cardiac death - How should we manage the risk?. N Engl J Med 2009;360:294-6. [Ref.ID 84997]
38. Cita con resumen
Brett AS. New approach to prevention of osteoporotic fractures. Journal Watch 2009;29:3-4. [Ref.ID 84964]
Kshirsagar AV, Bang H, Bomback AS, Vupputuri S, Shoham DA, Kern LM, Klemmer PJ, Mazumdar M, August PA. A simple algorithm to predict incident kidney disease. Arch Intern Med 2008;168:2466-73. [Ref.ID 84734]
40. Cita con resumen
Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008;66:758-66. [Ref.ID 84593]
Seleccionar todas
<< anterior 21 a 40 de 175 siguiente >>